Structure

Physi-Chem Properties

Molecular Weight:  302.17
Volume:  348.461
LogP:  5.706
LogD:  4.278
LogS:  -6.108
# Rotatable Bonds:  4
TPSA:  20.23
# H-Bond Aceptor:  1
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  1

MedChem Properties

QED Drug-Likeness Score:  0.656
Synthetic Accessibility Score:  2.707
Fsp3:  0.182
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.86
MDCK Permeability:  9.779611900739837e-06
Pgp-inhibitor:  0.933
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.945
30% Bioavailability (F30%):  0.122

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.463
Plasma Protein Binding (PPB):  99.51719665527344%
Volume Distribution (VD):  1.395
Pgp-substrate:  0.7575228214263916%

ADMET: Metabolism

CYP1A2-inhibitor:  0.656
CYP1A2-substrate:  0.891
CYP2C19-inhibitor:  0.924
CYP2C19-substrate:  0.692
CYP2C9-inhibitor:  0.824
CYP2C9-substrate:  0.974
CYP2D6-inhibitor:  0.301
CYP2D6-substrate:  0.21
CYP3A4-inhibitor:  0.741
CYP3A4-substrate:  0.844

ADMET: Excretion

Clearance (CL):  4.229
Half-life (T1/2):  0.058

ADMET: Toxicity

hERG Blockers:  0.015
Human Hepatotoxicity (H-HT):  0.189
Drug-inuced Liver Injury (DILI):  0.344
AMES Toxicity:  0.388
Rat Oral Acute Toxicity:  0.335
Maximum Recommended Daily Dose:  0.869
Skin Sensitization:  0.049
Carcinogencity:  0.161
Eye Corrosion:  0.003
Eye Irritation:  0.806
Respiratory Toxicity:  0.108

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC271274

Natural Product ID:  NPC271274
Common Name*:   2,4-Bis(1-Phenylethyl)Phenol
IUPAC Name:   2,4-bis(1-phenylethyl)phenol
Synonyms:   2,4-Bis(1-Phenylethyl)Phenol
Standard InCHIKey:  RCFAHSGZAAFQJH-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C22H22O/c1-16(18-9-5-3-6-10-18)20-13-14-22(23)21(15-20)17(2)19-11-7-4-8-12-19/h3-17,23H,1-2H3
SMILES:  CC(c1ccc(c(c1)C(c1ccccc1)C)O)c1ccccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL252313
PubChem CID:   102877
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002650] Diarylheptanoids
        • [CHEMONTID:0002651] Linear diarylheptanoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21390 Zanthoxylum integrifoliolum Species Rutaceae Eukaryota fruit Lanyu Island, Taitung County, Taiwan n.a. PMID[10395498]
NPO21390 Zanthoxylum integrifoliolum Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[17822293]
NPO7191 Mimosa pudica Species Fabaceae Eukaryota n.a. root n.a. PMID[26661932]
NPO7191 Mimosa pudica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO7191 Mimosa pudica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21390 Zanthoxylum integrifoliolum Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21390 Zanthoxylum integrifoliolum Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7191 Mimosa pudica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2740 Cell Line Neutrophils IC50 > 100000.0 nM PMID[464485]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC271274 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9592 High Similarity NPC51015
0.9333 High Similarity NPC715
0.9307 High Similarity NPC138942
0.93 High Similarity NPC168829
0.9286 High Similarity NPC77492
0.9231 High Similarity NPC296683
0.9208 High Similarity NPC288411
0.9143 High Similarity NPC95716
0.91 High Similarity NPC225506
0.9082 High Similarity NPC8392
0.9065 High Similarity NPC195922
0.9057 High Similarity NPC46940
0.9048 High Similarity NPC13482
0.9048 High Similarity NPC141782
0.9038 High Similarity NPC11554
0.9 High Similarity NPC252821
0.9 High Similarity NPC122005
0.899 High Similarity NPC473388
0.899 High Similarity NPC292730
0.899 High Similarity NPC216520
0.899 High Similarity NPC82664
0.899 High Similarity NPC132271
0.8962 High Similarity NPC176279
0.8962 High Similarity NPC260323
0.8952 High Similarity NPC58865
0.8952 High Similarity NPC314187
0.8942 High Similarity NPC151477
0.89 High Similarity NPC225464
0.8889 High Similarity NPC26244
0.8879 High Similarity NPC250323
0.8857 High Similarity NPC262365
0.8812 High Similarity NPC92730
0.8796 High Similarity NPC322239
0.8788 High Similarity NPC151715
0.8788 High Similarity NPC128062
0.8776 High Similarity NPC204210
0.8776 High Similarity NPC304541
0.875 High Similarity NPC117115
0.875 High Similarity NPC219286
0.875 High Similarity NPC99557
0.8716 High Similarity NPC268160
0.8704 High Similarity NPC228425
0.87 High Similarity NPC144682
0.8692 High Similarity NPC44732
0.8687 High Similarity NPC271440
0.8679 High Similarity NPC61885
0.8679 High Similarity NPC63698
0.8667 High Similarity NPC21594
0.8667 High Similarity NPC54765
0.8649 High Similarity NPC299180
0.8636 High Similarity NPC35797
0.8636 High Similarity NPC147179
0.8636 High Similarity NPC192948
0.8627 High Similarity NPC128723
0.8624 High Similarity NPC141003
0.8624 High Similarity NPC35344
0.8611 High Similarity NPC165770
0.8611 High Similarity NPC4493
0.8611 High Similarity NPC476632
0.8611 High Similarity NPC308689
0.8611 High Similarity NPC322753
0.8611 High Similarity NPC225679
0.8611 High Similarity NPC151537
0.8611 High Similarity NPC77772
0.86 High Similarity NPC76938
0.86 High Similarity NPC316301
0.86 High Similarity NPC27323
0.86 High Similarity NPC289769
0.86 High Similarity NPC152415
0.8586 High Similarity NPC45040
0.8571 High Similarity NPC318325
0.8571 High Similarity NPC258219
0.8571 High Similarity NPC280347
0.8571 High Similarity NPC123273
0.8571 High Similarity NPC70436
0.8571 High Similarity NPC242240
0.8571 High Similarity NPC177420
0.8559 High Similarity NPC471668
0.8559 High Similarity NPC308311
0.8559 High Similarity NPC308828
0.8559 High Similarity NPC477137
0.8559 High Similarity NPC219112
0.8559 High Similarity NPC38893
0.8559 High Similarity NPC261973
0.8545 High Similarity NPC12656
0.8545 High Similarity NPC107240
0.8532 High Similarity NPC228988
0.8532 High Similarity NPC43525
0.8532 High Similarity NPC286222
0.8529 High Similarity NPC79241
0.8529 High Similarity NPC6597
0.8515 High Similarity NPC32714
0.8515 High Similarity NPC274678
0.8505 High Similarity NPC95344
0.8491 Intermediate Similarity NPC248904
0.8485 Intermediate Similarity NPC55561
0.8482 Intermediate Similarity NPC477136
0.8482 Intermediate Similarity NPC16030
0.8482 Intermediate Similarity NPC304510
0.8482 Intermediate Similarity NPC172219
0.8476 Intermediate Similarity NPC238696
0.8469 Intermediate Similarity NPC25493
0.8469 Intermediate Similarity NPC113460
0.8468 Intermediate Similarity NPC84999
0.8468 Intermediate Similarity NPC246760
0.8462 Intermediate Similarity NPC12221
0.8455 Intermediate Similarity NPC321589
0.8455 Intermediate Similarity NPC117846
0.8447 Intermediate Similarity NPC216468
0.8447 Intermediate Similarity NPC78119
0.8447 Intermediate Similarity NPC132078
0.8447 Intermediate Similarity NPC51333
0.844 Intermediate Similarity NPC470770
0.844 Intermediate Similarity NPC266937
0.8431 Intermediate Similarity NPC259512
0.8431 Intermediate Similarity NPC312132
0.8426 Intermediate Similarity NPC228343
0.8426 Intermediate Similarity NPC254833
0.8411 Intermediate Similarity NPC228737
0.8411 Intermediate Similarity NPC320439
0.8407 Intermediate Similarity NPC469609
0.8407 Intermediate Similarity NPC471671
0.84 Intermediate Similarity NPC155908
0.84 Intermediate Similarity NPC306074
0.8396 Intermediate Similarity NPC474839
0.8393 Intermediate Similarity NPC92
0.8393 Intermediate Similarity NPC469663
0.8393 Intermediate Similarity NPC141001
0.8381 Intermediate Similarity NPC108497
0.8378 Intermediate Similarity NPC473137
0.8378 Intermediate Similarity NPC249270
0.8367 Intermediate Similarity NPC23167
0.8367 Intermediate Similarity NPC407
0.8367 Intermediate Similarity NPC307235
0.8365 Intermediate Similarity NPC213730
0.8365 Intermediate Similarity NPC211885
0.8365 Intermediate Similarity NPC72729
0.8364 Intermediate Similarity NPC62867
0.8364 Intermediate Similarity NPC177962
0.835 Intermediate Similarity NPC32674
0.835 Intermediate Similarity NPC156313
0.8349 Intermediate Similarity NPC132720
0.8333 Intermediate Similarity NPC176893
0.8333 Intermediate Similarity NPC222146
0.8333 Intermediate Similarity NPC469644
0.8333 Intermediate Similarity NPC126002
0.8333 Intermediate Similarity NPC93071
0.8333 Intermediate Similarity NPC201959
0.8333 Intermediate Similarity NPC151197
0.8317 Intermediate Similarity NPC306884
0.8317 Intermediate Similarity NPC94139
0.8317 Intermediate Similarity NPC147284
0.8317 Intermediate Similarity NPC162314
0.8317 Intermediate Similarity NPC210497
0.8317 Intermediate Similarity NPC3358
0.8304 Intermediate Similarity NPC469719
0.8302 Intermediate Similarity NPC119860
0.8302 Intermediate Similarity NPC323810
0.83 Intermediate Similarity NPC192
0.8288 Intermediate Similarity NPC317869
0.8286 Intermediate Similarity NPC91461
0.8286 Intermediate Similarity NPC7686
0.8286 Intermediate Similarity NPC252105
0.8286 Intermediate Similarity NPC40258
0.8273 Intermediate Similarity NPC224527
0.8269 Intermediate Similarity NPC299762
0.8269 Intermediate Similarity NPC33675
0.8265 Intermediate Similarity NPC197783
0.8265 Intermediate Similarity NPC155393
0.8261 Intermediate Similarity NPC135467
0.8261 Intermediate Similarity NPC69006
0.8261 Intermediate Similarity NPC103916
0.8261 Intermediate Similarity NPC260832
0.8235 Intermediate Similarity NPC245187
0.8224 Intermediate Similarity NPC303141
0.8224 Intermediate Similarity NPC243677
0.8224 Intermediate Similarity NPC154899
0.8224 Intermediate Similarity NPC239291
0.8224 Intermediate Similarity NPC233396
0.8214 Intermediate Similarity NPC471534
0.8208 Intermediate Similarity NPC135784
0.8208 Intermediate Similarity NPC269212
0.8205 Intermediate Similarity NPC71094
0.8205 Intermediate Similarity NPC176208
0.82 Intermediate Similarity NPC98772
0.8198 Intermediate Similarity NPC166995
0.8198 Intermediate Similarity NPC471179
0.819 Intermediate Similarity NPC248396
0.819 Intermediate Similarity NPC48730
0.819 Intermediate Similarity NPC259703
0.819 Intermediate Similarity NPC32322
0.819 Intermediate Similarity NPC129373
0.819 Intermediate Similarity NPC294741
0.8182 Intermediate Similarity NPC184169
0.8173 Intermediate Similarity NPC152097
0.8165 Intermediate Similarity NPC470039
0.8163 Intermediate Similarity NPC248817
0.8163 Intermediate Similarity NPC286904
0.8163 Intermediate Similarity NPC175313
0.8158 Intermediate Similarity NPC25648

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC271274 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9192 High Similarity NPD3020 Approved
0.8889 High Similarity NPD2859 Approved
0.8889 High Similarity NPD2860 Approved
0.8878 High Similarity NPD845 Approved
0.8788 High Similarity NPD2934 Approved
0.8788 High Similarity NPD2933 Approved
0.8762 High Similarity NPD2342 Discontinued
0.87 High Similarity NPD1809 Phase 2
0.86 High Similarity NPD1432 Clinical (unspecified phase)
0.8431 Intermediate Similarity NPD288 Approved
0.8426 Intermediate Similarity NPD3022 Approved
0.8426 Intermediate Similarity NPD3021 Approved
0.8364 Intermediate Similarity NPD7635 Approved
0.8333 Intermediate Similarity NPD844 Approved
0.8246 Intermediate Similarity NPD5303 Approved
0.8246 Intermediate Similarity NPD5304 Approved
0.8174 Intermediate Similarity NPD4093 Discontinued
0.8113 Intermediate Similarity NPD940 Approved
0.8113 Intermediate Similarity NPD846 Approved
0.8103 Intermediate Similarity NPD4589 Approved
0.8087 Intermediate Similarity NPD3091 Approved
0.8061 Intermediate Similarity NPD111 Approved
0.8019 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.7983 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7967 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7965 Intermediate Similarity NPD2228 Approved
0.7965 Intermediate Similarity NPD2229 Approved
0.7965 Intermediate Similarity NPD2234 Approved
0.7949 Intermediate Similarity NPD2286 Discontinued
0.7949 Intermediate Similarity NPD3019 Approved
0.7949 Intermediate Similarity NPD4059 Approved
0.7928 Intermediate Similarity NPD4750 Phase 3
0.7815 Intermediate Similarity NPD3092 Approved
0.7805 Intermediate Similarity NPD4908 Phase 1
0.7797 Intermediate Similarity NPD2932 Approved
0.7788 Intermediate Similarity NPD6124 Clinical (unspecified phase)
0.7768 Intermediate Similarity NPD1792 Phase 2
0.7759 Intermediate Similarity NPD7325 Clinical (unspecified phase)
0.7685 Intermediate Similarity NPD3028 Approved
0.7685 Intermediate Similarity NPD1242 Phase 1
0.7658 Intermediate Similarity NPD1445 Approved
0.7658 Intermediate Similarity NPD1444 Approved
0.7652 Intermediate Similarity NPD7159 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD3095 Discontinued
0.7611 Intermediate Similarity NPD5451 Approved
0.7561 Intermediate Similarity NPD4339 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD3094 Phase 2
0.7545 Intermediate Similarity NPD5700 Clinical (unspecified phase)
0.7521 Intermediate Similarity NPD1610 Phase 2
0.75 Intermediate Similarity NPD5238 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1751 Approved
0.7479 Intermediate Similarity NPD7330 Discontinued
0.746 Intermediate Similarity NPD5156 Approved
0.746 Intermediate Similarity NPD5155 Approved
0.744 Intermediate Similarity NPD5736 Approved
0.744 Intermediate Similarity NPD2861 Phase 2
0.7436 Intermediate Similarity NPD1476 Clinical (unspecified phase)
0.7422 Intermediate Similarity NPD4060 Phase 1
0.7398 Intermediate Similarity NPD6583 Phase 3
0.7398 Intermediate Similarity NPD6582 Phase 2
0.7381 Intermediate Similarity NPD2606 Approved
0.7381 Intermediate Similarity NPD2605 Approved
0.7377 Intermediate Similarity NPD1201 Approved
0.7373 Intermediate Similarity NPD6671 Approved
0.736 Intermediate Similarity NPD6584 Phase 3
0.7355 Intermediate Similarity NPD4626 Approved
0.735 Intermediate Similarity NPD5283 Phase 1
0.735 Intermediate Similarity NPD4869 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD2226 Clinical (unspecified phase)
0.7323 Intermediate Similarity NPD4625 Phase 3
0.7321 Intermediate Similarity NPD9610 Approved
0.7321 Intermediate Similarity NPD9608 Approved
0.7308 Intermediate Similarity NPD4097 Suspended
0.7302 Intermediate Similarity NPD3635 Approved
0.7302 Intermediate Similarity NPD3637 Approved
0.7302 Intermediate Similarity NPD3636 Approved
0.7295 Intermediate Similarity NPD3023 Approved
0.7295 Intermediate Similarity NPD3026 Approved
0.7288 Intermediate Similarity NPD497 Approved
0.728 Intermediate Similarity NPD1164 Approved
0.7273 Intermediate Similarity NPD4235 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD3024 Approved
0.7273 Intermediate Similarity NPD3025 Approved
0.7273 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7265 Intermediate Similarity NPD5535 Approved
0.7258 Intermediate Similarity NPD4659 Approved
0.7244 Intermediate Similarity NPD3594 Approved
0.7244 Intermediate Similarity NPD3595 Approved
0.7236 Intermediate Similarity NPD5351 Clinical (unspecified phase)
0.7236 Intermediate Similarity NPD5350 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD9500 Approved
0.7227 Intermediate Similarity NPD6387 Discontinued
0.7222 Intermediate Similarity NPD2194 Approved
0.7222 Intermediate Similarity NPD4624 Approved
0.7222 Intermediate Similarity NPD2195 Approved
0.7213 Intermediate Similarity NPD2667 Approved
0.7213 Intermediate Similarity NPD2668 Approved
0.7209 Intermediate Similarity NPD6663 Approved
0.7203 Intermediate Similarity NPD495 Approved
0.7203 Intermediate Similarity NPD498 Approved
0.7203 Intermediate Similarity NPD496 Approved
0.719 Intermediate Similarity NPD1548 Phase 1
0.7185 Intermediate Similarity NPD7003 Approved
0.7154 Intermediate Similarity NPD2688 Clinical (unspecified phase)
0.7154 Intermediate Similarity NPD3143 Discontinued
0.7153 Intermediate Similarity NPD7041 Phase 2
0.7153 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5408 Approved
0.7143 Intermediate Similarity NPD1470 Approved
0.7143 Intermediate Similarity NPD5406 Approved
0.7143 Intermediate Similarity NPD4104 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2797 Approved
0.7143 Intermediate Similarity NPD5405 Approved
0.7143 Intermediate Similarity NPD4103 Phase 2
0.7143 Intermediate Similarity NPD5404 Approved
0.7121 Intermediate Similarity NPD7718 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD4749 Approved
0.7087 Intermediate Similarity NPD7451 Discontinued
0.7077 Intermediate Similarity NPD6407 Approved
0.7077 Intermediate Similarity NPD6405 Approved
0.7073 Intermediate Similarity NPD6516 Phase 2
0.7073 Intermediate Similarity NPD5846 Approved
0.7069 Intermediate Similarity NPD2684 Approved
0.7063 Intermediate Similarity NPD1283 Approved
0.7049 Intermediate Similarity NPD6581 Approved
0.7049 Intermediate Similarity NPD6580 Approved
0.7043 Intermediate Similarity NPD968 Approved
0.704 Intermediate Similarity NPD2232 Approved
0.704 Intermediate Similarity NPD2233 Approved
0.704 Intermediate Similarity NPD2230 Approved
0.704 Intermediate Similarity NPD3070 Discontinued
0.7034 Intermediate Similarity NPD228 Approved
0.7027 Intermediate Similarity NPD9273 Approved
0.7025 Intermediate Similarity NPD7636 Approved
0.7023 Intermediate Similarity NPD3620 Phase 2
0.7023 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1793 Approved
0.7 Intermediate Similarity NPD1791 Approved
0.7 Intermediate Similarity NPD475 Phase 2
0.7 Intermediate Similarity NPD6798 Discontinued
0.7 Intermediate Similarity NPD3764 Approved
0.6992 Remote Similarity NPD6830 Clinical (unspecified phase)
0.6992 Remote Similarity NPD1651 Approved
0.6992 Remote Similarity NPD5691 Approved
0.6991 Remote Similarity NPD4818 Approved
0.6991 Remote Similarity NPD4817 Approved
0.6984 Remote Similarity NPD5327 Phase 3
0.6984 Remote Similarity NPD1669 Approved
0.6975 Remote Similarity NPD1138 Approved
0.6953 Remote Similarity NPD2798 Approved
0.6942 Remote Similarity NPD709 Approved
0.6942 Remote Similarity NPD7157 Approved
0.694 Remote Similarity NPD2799 Discontinued
0.694 Remote Similarity NPD1509 Clinical (unspecified phase)
0.694 Remote Similarity NPD7743 Approved
0.694 Remote Similarity NPD7742 Approved
0.694 Remote Similarity NPD3299 Clinical (unspecified phase)
0.6939 Remote Similarity NPD9087 Approved
0.693 Remote Similarity NPD4656 Approved
0.693 Remote Similarity NPD4231 Approved
0.693 Remote Similarity NPD4658 Approved
0.693 Remote Similarity NPD4229 Approved
0.6929 Remote Similarity NPD8651 Approved
0.6923 Remote Similarity NPD7095 Approved
0.6912 Remote Similarity NPD7037 Approved
0.6906 Remote Similarity NPD7390 Discontinued
0.6906 Remote Similarity NPD2420 Approved
0.6906 Remote Similarity NPD2421 Approved
0.6905 Remote Similarity NPD2562 Approved
0.6905 Remote Similarity NPD2561 Approved
0.6903 Remote Similarity NPD1616 Discontinued
0.6899 Remote Similarity NPD4208 Discontinued
0.6894 Remote Similarity NPD5837 Clinical (unspecified phase)
0.6894 Remote Similarity NPD4140 Approved
0.6891 Remote Similarity NPD1139 Approved
0.6891 Remote Similarity NPD1137 Approved
0.6889 Remote Similarity NPD2935 Discontinued
0.6885 Remote Similarity NPD7340 Approved
0.688 Remote Similarity NPD3847 Discontinued
0.688 Remote Similarity NPD1981 Approved
0.688 Remote Similarity NPD3421 Phase 3
0.688 Remote Similarity NPD1980 Approved
0.688 Remote Similarity NPD1983 Approved
0.6875 Remote Similarity NPD1131 Approved
0.6875 Remote Similarity NPD3053 Approved
0.6875 Remote Similarity NPD1133 Approved
0.6875 Remote Similarity NPD1129 Approved
0.6875 Remote Similarity NPD1135 Approved
0.6875 Remote Similarity NPD3055 Approved
0.6875 Remote Similarity NPD1134 Approved
0.687 Remote Similarity NPD3268 Approved
0.687 Remote Similarity NPD6410 Clinical (unspecified phase)
0.687 Remote Similarity NPD2028 Clinical (unspecified phase)
0.687 Remote Similarity NPD6812 Clinical (unspecified phase)
0.6866 Remote Similarity NPD3552 Approved
0.6866 Remote Similarity NPD3553 Approved
0.6866 Remote Similarity NPD3554 Approved
0.6866 Remote Similarity NPD3555 Approved
0.6864 Remote Similarity NPD9380 Clinical (unspecified phase)
0.6861 Remote Similarity NPD7421 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data